Maarten van der Zanden

CIO of Atro Medical

ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies and financial support from the Dutch government. The collaboration between the clinical, biomechanical and polymer experts has been instrumental in the development of our Meniscus Prosthesis.

Ranja Salvamoser

CEO of Mermaid Bio

Mermaid Bio’s Intrabodies represent a novel precision-medicine approach that can tackle notoriously difficult targets and is piloted directly to the tissue of interest to avoid damaging side effects.

Kurt Herpel

CEO of Delta4ai

A passionate team dedicated to finding effective treatments for complex diseases At Delta4 you’ll find computational biologists, medical experts, molecular biologists, full-stack developers, intellectual property experts, etc. An amazing group of people from a wide variety of backgrounds and uniquely talented in their specialties. What binds us all, the reason we’re excited to get to the office every morning, is our passion for helping patients around the world. There are millions of people who are afflicted by orphan diseases. We spend our days discovering the treatments that will improve their quality of life and then work hard to get them into their hands as soon as safely possible.

Kari Sarvanto

CEO of Cancer Research and Biotechnology AG

Cancer Research and Biotechnology AG is a Swiss preclinical oncology company focusing on metabolic diseases and mitochondrial healing for cancer treatments. CRB is developing new-generation cancer treatments that selectively eradicate cancer cells without inducing toxicity.

Raphaël Ognar

CEO of NKILT Therapeutics

Engineering the future of targeting NK-cell therapy against cancer NKILT Therapeutics is a new cell therapy biotech developing a novel approach to engineering immune cells, starting with natural killer (NK) cells, to directly target leukemias and solid tumors.

Shy Zyman

CEO at PreciHealth

Preci-HealthTM is revolutionizing the landscape of medical care by providing accessible, safe and virtually painless solutions for blood sampling and injections – anytime, anywhere. Our vision is to ensure every individual has the tools needed to manage their health with unprecedented accuracy and ease – ultimately, leading to informed decision making and improved healthcare outcomes.